The Avellino Universal test is a commercially available genetic diagnostic assay to detect the presence of
TGFBI corneal dystrophy.
As with all diagnostics from Avellino, the Universal test offers genetic data in a straightforward manner to
provide physicians with personalized medical information for improving the quality of an individual’s health
and life decisions.
Granular Corneal Dystrophy type 1
Granular Corneal Dystrophy type 2
Lattice Corneal Dystrophy type 1
Reis-Bucklers Corneal Dystrophy
Theil-Behnke Corneal Dystrophy
Forms for the Avellino Universal test to determine the presence of corneal dystrophies can be found here.
Another clinical option for your patients is the new AvaGen test, which determines the risk of developing keratoconus and the presence of corneal dystrophies.
Utilizing a custom panel, AvaGen examines over 1,000 variants across 75 genes for keratoconus and over 70 mutations for corneal dystrophies (compared to the 5 mutations tested for in the Universal test) to proactively diagnose conditions even before symptoms may appear.
Available in the United States in late 2019/early 2020.